These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21261868)

  • 21. Probing the heterologous metabolism supporting 6-deoxyerythronolide B biosynthesis in Escherichia coli.
    Zhang H; Wang Y; Boghigian B; Pfeifer BA
    Microb Biotechnol; 2009 May; 2(3):390-4. PubMed ID: 21261933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative sigma factor over-expression enables heterologous expression of a type II polyketide biosynthetic pathway in Escherichia coli.
    Stevens DC; Conway KR; Pearce N; Villegas-Peñaranda LR; Garza AG; Boddy CN
    PLoS One; 2013; 8(5):e64858. PubMed ID: 23724102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of glycosyltransferase DesVII and its auxiliary partner protein DesVIII in the methymycin/picromycin biosynthetic pathway.
    Borisova SA; Liu HW
    Biochemistry; 2010 Sep; 49(37):8071-84. PubMed ID: 20695498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combinatorial biosynthesis of plant medicinal polyketides by microorganisms.
    Horinouchi S
    Curr Opin Chem Biol; 2009 Apr; 13(2):197-204. PubMed ID: 19264534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered biosynthesis of bacterial aromatic polyketides in Escherichia coli.
    Zhang W; Li Y; Tang Y
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20683-8. PubMed ID: 19075227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of pathway genes for polyketide biosynthesis.
    Peirú S; Gramajo H; Menzella HG
    Methods Enzymol; 2009; 459():319-37. PubMed ID: 19362646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fermenting next generation glycosylated therapeutics.
    Chen X
    ACS Chem Biol; 2011 Jan; 6(1):14-7. PubMed ID: 21250649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The logic, experimental steps, and potential of heterologous natural product biosynthesis featuring the complex antibiotic erythromycin A produced through E. coli.
    Jiang M; Zhang H; Pfeifer BA
    J Vis Exp; 2013 Jan; (71):e4346. PubMed ID: 23354010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosome engineering of Escherichia coli for constitutive production of salvianic acid A.
    Zhou L; Ding Q; Jiang GZ; Liu ZN; Wang HY; Zhao GR
    Microb Cell Fact; 2017 May; 16(1):84. PubMed ID: 28511681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells.
    Wang K; Zhou L; Chen T; Li Q; Li J; Liu L; Li Y; Sun J; Li T; Wang Y; Kong Z; Zheng Q; Zhang J; Yu H; Gu Y; Xia N; Li S
    Microb Cell Fact; 2021 Dec; 20(1):227. PubMed ID: 34930257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives.
    Baeshen MN; Al-Hejin AM; Bora RS; Ahmed MM; Ramadan HA; Saini KS; Baeshen NA; Redwan EM
    J Microbiol Biotechnol; 2015 Jul; 25(7):953-62. PubMed ID: 25737124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous production and partitioning of heterologous polyketide and isoprenoid natural products in an Escherichia coli two-phase bioprocess.
    Boghigian BA; Myint M; Wu J; Pfeifer BA
    J Ind Microbiol Biotechnol; 2011 Nov; 38(11):1809-20. PubMed ID: 21487833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tools for metabolic engineering in Escherichia coli: inactivation of panD by a point mutation.
    Kennedy J; Kealey JT
    Anal Biochem; 2004 Apr; 327(1):91-6. PubMed ID: 15033515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of genes involved in 6-deoxyhexose biosynthesis and transfer in Saccharopolyspora erythraea.
    Doumith M; Weingarten P; Wehmeier UF; Salah-Bey K; Benhamou B; Capdevila C; Michel JM; Piepersberg W; Raynal MC
    Mol Gen Genet; 2000 Nov; 264(4):477-85. PubMed ID: 11129052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved phloroglucinol production by metabolically engineered Escherichia coli.
    Cao Y; Jiang X; Zhang R; Xian M
    Appl Microbiol Biotechnol; 2011 Sep; 91(6):1545-52. PubMed ID: 21643705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineered Biosynthesis of Medicinally Important Plant Natural Products in Microorganisms.
    Zhang S; Wang S; Zhan J
    Curr Top Med Chem; 2016; 16(15):1740-54. PubMed ID: 26456465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of domains within megalomicin and erythromycin polyketide synthase modules responsible for differences in polyketide production levels in Escherichia coli.
    Murli S; Piagentini M; McDaniel R; Hutchinson CR
    Biochemistry; 2004 Dec; 43(50):15884-90. PubMed ID: 15595843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved E. coli erythromycin A production through the application of metabolic and bioprocess engineering.
    Zhang H; Skalina K; Jiang M; Pfeifer BA
    Biotechnol Prog; 2012; 28(1):292-6. PubMed ID: 21905273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli.
    Pfeifer BA; Admiraal SJ; Gramajo H; Cane DE; Khosla C
    Science; 2001 Mar; 291(5509):1790-2. PubMed ID: 11230695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo biosynthesis of complex natural product sakuranetin using modular co-culture engineering.
    Wang X; Li Z; Policarpio L; Koffas MAG; Zhang H
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4849-4861. PubMed ID: 32285175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.